Correlation Between Trevi Therapeutics and Dyne Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Trevi Therapeutics and Dyne Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Trevi Therapeutics and Dyne Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Trevi Therapeutics and Dyne Therapeutics, you can compare the effects of market volatilities on Trevi Therapeutics and Dyne Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Trevi Therapeutics with a short position of Dyne Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Trevi Therapeutics and Dyne Therapeutics.

Diversification Opportunities for Trevi Therapeutics and Dyne Therapeutics

0.18
  Correlation Coefficient

Average diversification

The 3 months correlation between Trevi and Dyne is 0.18. Overlapping area represents the amount of risk that can be diversified away by holding Trevi Therapeutics and Dyne Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dyne Therapeutics and Trevi Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Trevi Therapeutics are associated (or correlated) with Dyne Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dyne Therapeutics has no effect on the direction of Trevi Therapeutics i.e., Trevi Therapeutics and Dyne Therapeutics go up and down completely randomly.

Pair Corralation between Trevi Therapeutics and Dyne Therapeutics

Given the investment horizon of 90 days Trevi Therapeutics is expected to under-perform the Dyne Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Trevi Therapeutics is 1.3 times less risky than Dyne Therapeutics. The stock trades about -0.06 of its potential returns per unit of risk. The Dyne Therapeutics is currently generating about -0.02 of returns per unit of risk over similar time horizon. If you would invest  3,110  in Dyne Therapeutics on August 25, 2024 and sell it today you would lose (141.00) from holding Dyne Therapeutics or give up 4.53% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Trevi Therapeutics  vs.  Dyne Therapeutics

 Performance 
       Timeline  
Trevi Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Trevi Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Trevi Therapeutics is not utilizing all of its potentials. The latest stock price confusion, may contribute to short-horizon losses for the traders.
Dyne Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Dyne Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of conflicting performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.

Trevi Therapeutics and Dyne Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Trevi Therapeutics and Dyne Therapeutics

The main advantage of trading using opposite Trevi Therapeutics and Dyne Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Trevi Therapeutics position performs unexpectedly, Dyne Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dyne Therapeutics will offset losses from the drop in Dyne Therapeutics' long position.
The idea behind Trevi Therapeutics and Dyne Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Other Complementary Tools

Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Fundamental Analysis
View fundamental data based on most recent published financial statements
Stocks Directory
Find actively traded stocks across global markets
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume